- Published on 28 April 2016
Access to hearing healthcare
Researchers from the National Acoustic Laboratories and the Hearing CRC, New South Wales, Australia, recently published a review of the status of self-fitting hearing aids (SFHAs).
The researchers describe the concept of SFHA as self-contained units that can be adjusted without requiring access to other hardware or an internet connection, and that can be fitted by the users themselves without needing help from a hearing healthcare professional. Fitting involves obtaining the initial hearing aid setting from threshold data and self-directed fine tuning to achieve personalized settings.
This type of system is considered beneficial especially in developing countries and for remote areas of developed countries, such as in Australia. A number of products available in the direct-to-consumer market were assessed. Concerning outcomes, the review found that the main issues involved in successful use of these devices were the technical characteristics of the hearing aid and person-directed factors that include ease of insertion, clarity of instructions given, and an intuitive response interface. Other challenges for developing countries are affordability and sustainable delivery systems.
In terms of future perspectives, the authors expect that use of SFHAs will grow, with most future products consisting of earpieces that connect wirelessly to a smartphone and providers offering assistance through telehealth infrastructures. They also believe that SFHAs will be integrated into the traditional hearing healthcare model. Full details can be found in the review published in the journal Trends in Hearing in mid-April.
Source: Keidser G, et al. Self-Fitting Hearing Aids: Status Quo and Future Predictions. Trends in Hearing. 2016 Apr 12;20.
The standards applied in testing for US authorisation for self-fitting hearing aids may "jeopardise the hearing health of consumers", says the Hearing Industries Association (HIA) in a letter to the issuing body, the Food and Drug Administration (FDA).
Widespread backing in US audiology supports the introduction of the bipartisan, bicameral Medicare Audiologist Access and Services Act of 2019, already before the US House of Representatives and soon to be put to the Senate.
If the mice are right, there is a drug fix for age-related hearing loss just around the next bureaucratic corner: the hormone aldosterone, combined with anti-inflammatory medicine, can rejuvenate hearing, says the team behind the development.
Audiologists from Australia's Royal Brisbane and Women's Hospital (RBWH) have helped update a recently developed app—HEAROES—designed to help new cochlear implant (CI) users adjust to their new sound environment.
The number of US citizens with eustachian tube dysfunction (ETD), barring those with recent colds, was previously estimated at under 1%, but a new study puts the figure at 4.6%, some 11m people. And the researchers say their figure may underestimate the condition's true prevalence.
Phonak, the world’s leading hearing aid provider, has launched Marvel 2.0, "the next generation of Marvel technology developed to give hearing aid wearers even more hearing performance, more connectivity and more choice".[ ... ]